SYK: Stryker Corporation Company Profile & Statistics

About

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

Info & Links

CEO

Kevin A. Lobo

Headquarters

1941 Stryker Way
Portage, MI 49002, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

2,510

Employees

53,000

Stryker Corporation Statistics

Valuation Measures

Market Capitalization²

145.95B

Enterprise Value

155.90B

Enterprise Value/EBITDA(ttm)

32.90

Price to Earnings Ratio(ttm)

31.70

Price to Sales(ttm)

6.53

Price to Book(mrq)

7.14

Price to Cash(ytd)

25.62

Profitability

Gross Margin(ttm)

63.86%

Operating Margin(ttm)

20.80%

Profit Margin(ttm)

13.48%

Return on Equity(ttm)

23.58%

Return on Invested Capital(ttm)

9.54%

Return on Assets(ttm)

11.37%

Income Statement

Revenue(ttm)

22.59B

Revenue Per Share(ttm)

59.21

Gross Profit(ttm)

14.44B

EBITDA(ttm)³

4.74B

Net Income Available to Common(ttm)

2.99B

Diluted EPS(ttm)

7.76

Share Statistics

Beta (5Y Monthly)

0.96

52-Week Change

11.18%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

381.58M

Dividend Yield

0.87%

Float⁴

359.07M

% Held by Insiders

5.90%

% Held by Institutions

77.09%

Balance Sheet

Total Cash(mrq)

4.49B

Total Cash Per Share(mrq)

11.77

Total Debt(mrq)

13.60B

Total Debt/Equity(mrq)

65.90%

Current Ratio(mrq)

1.95%

Quick Ratio(mrq)

1.32%

Book Value Per Share(mrq)

54.10

Cash Flow

Operating Cash Flow Per Share(ytd)

11.00

Free Cash Flow(ytd)

3.49B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SYK

Stryker Corporation

Stryker Corporation Profile